Addictions Therapeutics Market Analysis Through 2030: Market Size, Growth Trends And Industry Outlook
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Addictions Therapeutics Market Expansion Outlook: What Revenue Opportunities Are Ahead?
The addictions therapeutics market has demonstrated strong growth in recent years. It is anticipated to increase from $7.46 billion in 2025 to $7.93 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.2%. The expansion observed historically is attributable to a rising prevalence of substance use disorders, heightened awareness concerning addiction treatment, an increasing number of specialized treatment centers, the implementation of buprenorphine and naltrexone therapies, and the broadening of hospital and clinical networks.
The addictions therapeutics market is anticipated to experience substantial expansion over the forthcoming years. It is projected to reach $10.24 billion by 2030, driven by a compound annual growth rate (CAGR) of 6.6%. This predicted growth during the forecast period is fueled by the development of innovative addiction therapeutics, increased governmental and private investment in substance use disorder (SUDs) programs, the proliferation of telehealth and digital treatment platforms, greater integration of mental health and addiction services, and the broadening of public-private collaborations in addiction care. Prominent developments in this period will involve a rising demand for medication-assisted treatment (MAT), the expansion of inpatient and outpatient addiction treatment facilities, wider adoption of telehealth and remote counseling services, a stronger focus on therapies for nicotine and opioid addiction, and improved awareness initiatives for substance use disorders.
Get A Free Sample Report With In-Depth Market Insights:
Addictions Therapeutics Market Growth Backed By Core Demand Fundamentals
A growing intake of alcohol is projected to propel the addiction therapeutics market forward. Alcohol consumption involves consuming beverages containing ethyl alcohol. Addiction therapeutics are employed to manage alcohol addiction, helping individuals decrease their intake by counteracting the substance’s depressive effects and promoting equilibrium between the excitatory (glutamate) and inhibitory (gamma-aminobutyric acid) neurotransmitters. This action reduces alcohol cravings and alleviates symptoms such as insomnia, anxiety, and restlessness linked to alcohol withdrawal. For example, in December 2024, Kirin Holdings Co. Ltd., a Japan-based alcoholic and non-alcoholic beverage and pharmaceuticals product company, indicated that global beer consumption in 2023 increased by approximately 200,000 kl from 2022, reaching about 187.9 million kl, which is roughly equivalent to 296.9 billion 633 ml bottles, representing a modest 0.1% year-over-year growth. Consequently, the rising consumption of alcohol is driving the addiction therapeutics market.
Addictions Therapeutics Market Segment Landscape And Growth Outlook
The addictions therapeutics market covered in this report is segmented –
1) By Drug Type: Buprenorphine, Naltrexone, Bupropion, Disulfiram, Nicotine Replacement Products, Varenicline, Other Drugs
2) By Treatment Type: Opioid Addiction Treatment, Alcohol Addiction Treatment, Nicotine Addiction Treatment, Other Substance Addiction Treatment
3) By Treatment Center: Inpatient Treatment Center, Residential Treatment Center, Outpatient Treatment Center
4) By Distribution Channel: Hospital Pharmacies, Medical Stores, Other Distribution Channel
Subsegments:
1) By Buprenorphine: Subutex, Suboxone
2) By Naltrexone: Oral Naltrexone, Extended-Release Naltrexone (Vivitrol)
3) By Bupropion: Wellbutrin, Zyban
4) By Disulfiram: Antabuse, Generic Disulfiram
5) By Nicotine Replacement Products: Nicotine Patches, Nicotine Gum, Nicotine Inhalers, Nicotine Lozenges
6) By Varenicline: Chantix (Champix), Generic Varenicline
7) By Other Drugs: Acamprosate, Topiramate, Gabapentin
Addictions Therapeutics Market Growth Trends Reshaping The Competitive Landscape
Leading companies within the addiction therapeutics market are actively developing innovative products, such as medications for cocaine use disorders (CUD), to attract broader customer bases, boost sales, and generate increased revenue. Drugs for cocaine use disorders (CUD) are pharmaceuticals created to assist individuals dealing with cocaine addiction or dependence. For instance, in January 2023, Tempero Bio, a US-based biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had approved its investigational candidate, TMP-301. The distinctive feature of TMP-301 lies in its capacity to act as a metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator (NAM). TMP-301 is specifically engineered for its significant role in treating cocaine use disorders (CUD), notable for its potency, selectivity, and oral availability, all aimed at effectively reducing the excessive glutamate signaling linked to CUD.
Addictions Therapeutics Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the addictions therapeutics market are Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Perrigo Company plc, Purdue Pharma L.P., Dr. Reddy’s Laboratories Ltd., Cipla Inc., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Mallinckrodt Plc, Alkermes plc., Glenmark Pharmaceuticals Limited, Indivior plc., Lannett Company Inc., BioDelivery Sciences International Inc., Camurus AB, Orexo AB, Elite Pharmaceuticals Inc., Braeburn Inc., Titan Pharmaceuticals Inc., BioCorRx Inc.
View The Full Addictions Therapeutics Market Report:
Addictions Therapeutics Market Regional Analysis And Top Geography
North America was the largest region in the addictions therapeutics market in 2025. The regions covered in the addictions therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
